Curetis Announces Positive Top Line Data from U.S. FDA Trial
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
Roche today announced the global launch of new software updates, including advanced high- resolution melting analysis an…
Today Roche announced the global launch of its new LightCycler 96 System, which completes its portfolio of Real Time PCR…
MAB Discovery, a provider of exceptional therapeutic monoclonal antibodies, announced today that they have initiated two…
. - Both products receive 510(k) clearance for in vitro diagnostic use in the U.S. - Rotor-Gene Q MDx platform offers…
Today Roche announced the global launch of its new High Pure FFPET RNA Isolation Kit as well as the RealTime ready cDNA…
Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the…
To ensure product safety, clearance of host-cell DNA is essential when manufacturing therapeutic proteins and monoclonal…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at M…
. - Diagnostic workflow for C. difficile is launched in Europe and submitted in the U.S. for 510(k) clearance as the fi…